• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关基质在三阴性乳腺癌中的预后影响

Prognostic impact of tumor‑associated stroma in triple-negative breast cancer.

作者信息

Kakumoto Akinari, Jamiyan Tsengelmaa, Koyanagi Ai, Kuroda Hajime, Yamaguchi Rin, Tsuda Hitoshi, Hirano Akira, Shiozawa Shunichi

机构信息

Department of Diagnostic Pathology, Tokyo Women's Medical University Adachi Medical Center, 4-33-1 Kohoku, Adachi-ku, Tokyo, 123-8558, Japan.

Department of Pathology and Forensic Medicine, Mongolian National University of Medical Sciences, Ulan Bator, 14210, Mongolia.

出版信息

Breast Cancer. 2025 Mar;32(2):347-356. doi: 10.1007/s12282-024-01661-8. Epub 2024 Dec 18.

DOI:10.1007/s12282-024-01661-8
PMID:39695043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11842419/
Abstract

AIM

To establish the histological categorization of tumor‑associated stroma (TAS) that reflects the biological behavior of triple-negative breast cancer (TNBC).

METHODS AND RESULTS

One-hundred-and-twenty surgically resected cases of TNBC were examined. We histologically categorized the TAS in the invasive frontal region into two groups: mature stroma (MS) and immature stroma (IS). The designation of IS was applied for tumors in which the largest myxoid stroma filled a high-power magnification field. When there were no myxoid stroma that meet the criteria for IS, TAS was categorized as MS. The tumors with type MS were observed in 103 (85.8%) of patients, whereas 17 (14.2%) of patients had tumors with IS. In total, 72 out of 120 patients with TNBC exhibited high tumor-infiltrating lymphocytes (TILs) representing 60% of the cohort. The incidences of high TILs were 66% (68 out of 103) in the MS group but only 23.5% (4 of 17) in the IS group (p = 0.001). Progression-free survival (PFS) and overall survival (OS) curves were different between IS and MS groups (p < 0.001 each), and Cox multivariate regression analysis revealed that IS was an independent indicator for lower PFS and OS rates (p < 0.001; p = 0.008).

CONCLUSION

Our findings suggest that TAS characteristics, particularly the distinction between IS and MS, play a significant role in the prognosis of TNBC. The presence of IS, associated with poor prognosis and low TILs, contrasts with the favorable outcomes observed in cases with MS. Understanding these TAS dynamics could aid in identifying patients with varying prognostic outcomes in TNBC, necessitating further research into the mechanisms behind these observations.

摘要

目的

建立反映三阴性乳腺癌(TNBC)生物学行为的肿瘤相关间质(TAS)组织学分类。

方法与结果

对120例手术切除的TNBC病例进行检查。我们将浸润前沿区域的TAS组织学分为两组:成熟间质(MS)和未成熟间质(IS)。IS定义为最大黏液样间质充满高倍视野的肿瘤。当不存在符合IS标准的黏液样间质时,TAS分类为MS。103例(85.8%)患者的肿瘤为MS型,而17例(14.2%)患者的肿瘤为IS型。120例TNBC患者中,共有72例表现为高肿瘤浸润淋巴细胞(TILs),占队列的60%。MS组高TILs发生率为66%(103例中的68例),而IS组仅为23.5%(17例中的4例)(p = 0.001)。IS组和MS组的无进展生存期(PFS)和总生存期(OS)曲线不同(每组p < 0.001),Cox多因素回归分析显示,IS是PFS和OS率较低的独立指标(p < 0.001;p = 0.008)。

结论

我们的研究结果表明,TAS特征,特别是IS和MS之间的区别,在TNBC的预后中起重要作用。IS的存在与预后不良和低TILs相关,与MS病例观察到的良好结果形成对比。了解这些TAS动态变化有助于识别TNBC中预后不同的患者,需要进一步研究这些观察结果背后的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/3fcf3eeba9a5/12282_2024_1661_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/f32c104b829c/12282_2024_1661_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/4fb7ea342d15/12282_2024_1661_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/06db6fd3333a/12282_2024_1661_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/9fa1035da3d0/12282_2024_1661_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/3fcf3eeba9a5/12282_2024_1661_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/f32c104b829c/12282_2024_1661_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/4fb7ea342d15/12282_2024_1661_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/06db6fd3333a/12282_2024_1661_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/9fa1035da3d0/12282_2024_1661_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df80/11842419/3fcf3eeba9a5/12282_2024_1661_Fig5_HTML.jpg

相似文献

1
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer.肿瘤相关基质在三阴性乳腺癌中的预后影响
Breast Cancer. 2025 Mar;32(2):347-356. doi: 10.1007/s12282-024-01661-8. Epub 2024 Dec 18.
2
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.肿瘤-宿主界面处肿瘤浸润淋巴细胞的CD4/CD8比值在三阴性乳腺癌中具有预后价值。
Hum Pathol. 2017 Nov;69:110-117. doi: 10.1016/j.humpath.2017.09.012. Epub 2017 Oct 6.
3
Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study.病理检查中黏液样基质改变和纤维灶的存在是三阴性乳腺癌的预后因素:一项回顾性单中心研究的结果。
PLoS One. 2021 Feb 11;16(2):e0245725. doi: 10.1371/journal.pone.0245725. eCollection 2021.
4
The prognostic value of the tumor-stroma ratio compared to tumor-infiltrating lymphocytes in triple-negative breast cancer: a review.三阴性乳腺癌中肿瘤-基质比与肿瘤浸润淋巴细胞相比的预后价值:综述
Virchows Arch. 2025 Mar;486(3):427-444. doi: 10.1007/s00428-025-04039-z. Epub 2025 Feb 4.
5
The Conflicting Prognostic Role of the Stroma-Tumor Ratio in Breast Cancer Molecular Subtypes.基质-肿瘤比率在乳腺癌分子亚型中的预后作用冲突
Mod Pathol. 2024 Dec;37(12):100607. doi: 10.1016/j.modpat.2024.100607. Epub 2024 Aug 30.
6
Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer.新辅助治疗前后三阴性和 HER2 阳性乳腺癌中基质肿瘤浸润淋巴细胞的预测和预后价值。
Eur J Cancer. 2019 Sep;118:41-48. doi: 10.1016/j.ejca.2019.05.014. Epub 2019 Jul 11.
7
Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.三级淋巴结构:三阴性乳腺癌中的预后意义及其与肿瘤浸润淋巴细胞的关系
J Clin Pathol. 2016 May;69(5):422-30. doi: 10.1136/jclinpath-2015-203089. Epub 2015 Oct 16.
8
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.CD4和CD8阳性T细胞浸润增加表明三阴性乳腺癌的一个亚组预后良好。
Breast Cancer Res Treat. 2016 Apr;156(2):237-47. doi: 10.1007/s10549-016-3743-x. Epub 2016 Mar 9.
9
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.组织病理学、肿瘤浸润淋巴细胞和辅助化疗对三阴性乳腺癌预后的影响。
Breast Cancer Res Treat. 2018 Jan;167(1):89-99. doi: 10.1007/s10549-017-4499-7. Epub 2017 Sep 14.
10
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.TNFR2+ TILs 与三阴性乳腺癌患者的生存改善显著相关。
Cancer Immunol Immunother. 2020 Jul;69(7):1315-1326. doi: 10.1007/s00262-020-02549-0. Epub 2020 Mar 20.

本文引用的文献

1
Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast.肿瘤浸润 B 细胞和 T 细胞与三阴性乳腺癌的术后预后相关。
BMC Cancer. 2021 Mar 16;21(1):286. doi: 10.1186/s12885-021-08009-x.
2
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer.肿瘤浸润 B 淋巴细胞和浆细胞对三阴性乳腺癌的预后价值。
Breast Cancer. 2021 Jul;28(4):904-914. doi: 10.1007/s12282-021-01227-y. Epub 2021 Feb 25.
3
Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study.
病理检查中黏液样基质改变和纤维灶的存在是三阴性乳腺癌的预后因素:一项回顾性单中心研究的结果。
PLoS One. 2021 Feb 11;16(2):e0245725. doi: 10.1371/journal.pone.0245725. eCollection 2021.
4
CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.CD68 和 CD163 阳性的肿瘤相关巨噬细胞在三阴性乳腺癌中的表达。
Virchows Arch. 2020 Dec;477(6):767-775. doi: 10.1007/s00428-020-02855-z. Epub 2020 Jun 30.
5
Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast.肿瘤浸润淋巴细胞亚型对三阴性乳腺癌的预后影响。
Breast Cancer. 2020 Sep;27(5):880-892. doi: 10.1007/s12282-020-01084-1. Epub 2020 Mar 28.
6
The 2019 World Health Organization classification of tumours of the breast.《2019年世界卫生组织乳腺肿瘤分类》
Histopathology. 2020 Aug;77(2):181-185. doi: 10.1111/his.14091. Epub 2020 Jul 29.
7
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.乳腺癌中雌激素和孕激素受体检测:ASCO/CAP 指南更新。
J Clin Oncol. 2020 Apr 20;38(12):1346-1366. doi: 10.1200/JCO.19.02309. Epub 2020 Jan 13.
8
Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer.肿瘤间质类型与间质 PD-L1 表达相关,并可预测乳腺癌的预后。
PLoS One. 2019 Oct 4;14(10):e0223325. doi: 10.1371/journal.pone.0223325. eCollection 2019.
9
Cancer-Associated Fibroblasts and Desmoplastic Reactions Related to Cancer Invasiveness in Patients With Colorectal Cancer.结直肠癌患者中与癌症侵袭相关的癌症相关成纤维细胞和促结缔组织增生性反应
Ann Coloproctol. 2019 Feb;35(1):36-46. doi: 10.3393/ac.2018.09.10. Epub 2019 Feb 28.
10
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.肿瘤浸润淋巴细胞与预后:早期三阴性乳腺癌患者的汇总分析。
J Clin Oncol. 2019 Mar 1;37(7):559-569. doi: 10.1200/JCO.18.01010. Epub 2019 Jan 16.